Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen E Georgescu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Advances in Clinical Chemistry|September 29, 2015
Polycystic Ovary Syndrome-Epigenetic Mechanisms and Aberrant MicroRNAIoana R Ilie, Carmen E Georgescu
Frontiers in Endocrinology|February 13, 2016
Multiple Pituitary Adenomas: A Systematic ReviewRenata M Budan, Carmen E Georgescu
Frontiers in Endocrinology|February 2, 2019
Metabolomics-A Promising Approach to Pituitary AdenomasOana Pînzariu, Bogdan Georgescu, Carmen E Georgescu
Scandinavian Journal of Clinical and Laboratory Investigation|March 1, 2016
Determinants of visfatin in type 2 diabetes patients with diabetic kidney disease: Relationship to inflammation, adiposity and undercarboxylated osteocalcinAlex C Kacso, Cosmina I Bondor, Anca L Coman, et al.
Cancer Treatment Reviews|July 4, 2015
PI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinomaMirela S Petrulea, Theo S Plantinga, Jan W Smit, et al.
Endocrine Connections|October 28, 2020
Akt1 genetic variants confer increased susceptibility to thyroid cancerThomas Crezee, Mirela Petrulea, Doina Piciu, et al.
Endocrine-Related Cancer|April 22, 2017
Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinomaTheo S Plantinga, Mirela S Petrulea, Marije Oosting, et al.
Pituitary|March 25, 2026
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 studyMaria Fleseriu, Beverly M K Biller, Susan M Webb, et al.
European Journal of Endocrinology|September 18, 2025
Prospective study of metyrapone in endogenous Cushing's syndrome (PROMPT)Lynnette K Nieman, Marco Boscaro, Carla Scaroni, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Advances in Clinical Chemistry|September 29, 2015
Polycystic Ovary Syndrome-Epigenetic Mechanisms and Aberrant MicroRNAIoana R Ilie, Carmen E Georgescu
Frontiers in Endocrinology|February 13, 2016
Multiple Pituitary Adenomas: A Systematic ReviewRenata M Budan, Carmen E Georgescu
Frontiers in Endocrinology|February 2, 2019
Metabolomics-A Promising Approach to Pituitary AdenomasOana Pînzariu, Bogdan Georgescu, Carmen E Georgescu
Scandinavian Journal of Clinical and Laboratory Investigation|March 1, 2016
Determinants of visfatin in type 2 diabetes patients with diabetic kidney disease: Relationship to inflammation, adiposity and undercarboxylated osteocalcinAlex C Kacso, Cosmina I Bondor, Anca L Coman, et al.
Cancer Treatment Reviews|July 4, 2015
PI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinomaMirela S Petrulea, Theo S Plantinga, Jan W Smit, et al.
Endocrine Connections|October 28, 2020
Akt1 genetic variants confer increased susceptibility to thyroid cancerThomas Crezee, Mirela Petrulea, Doina Piciu, et al.
Endocrine-Related Cancer|April 22, 2017
Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinomaTheo S Plantinga, Mirela S Petrulea, Marije Oosting, et al.
Pituitary|March 25, 2026
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 studyMaria Fleseriu, Beverly M K Biller, Susan M Webb, et al.
European Journal of Endocrinology|September 18, 2025
Prospective study of metyrapone in endogenous Cushing's syndrome (PROMPT)Lynnette K Nieman, Marco Boscaro, Carla Scaroni, et al.
Pageof 1